精神心理科威廉亚洲博彩公司

订阅

MedSci主页 / 所有栏目 / 精神心理科威廉亚洲博彩公司

2020 日本专家共识：抑郁症的药物治疗

2020-01-28 国外精神科相关专家小组（统称） J Affect Disord. 2020 Jan 28;266:626-632.

抑郁症药物治疗

2020年1月，日本临床神经精神药理学学会(JSCNP)发布了抑郁症的药物治疗专家共识，真实世界抑郁症治疗的临床相关问题并没总被常规治疗威廉亚洲博彩公司 所涉及，日本临床神经精神药理学学会(JSCNP)专家组对23种抑郁症临床治疗情况的治疗方案进行评估，形成专家共识。

中文标题：

2020 日本专家共识：抑郁症的药物治疗

英文标题：

Pharmacological management of depression: Japanese expert consensus.

发布机构：

国外精神科相关专家小组（统称）

发布日期：

2020-01-28

简要介绍：

2020年1月，日本临床神经精神药理学学会(JSCNP)发布了抑郁症的药物治疗专家共识，真实世界抑郁症治疗的临床相关问题并没总被常规治疗威廉亚洲博彩公司 所涉及，日本临床神经精神药理学学会(JSCNP)专家组对23种抑郁症临床治疗情况的治疗方案进行评估，形成专家共识。

 

拓展威廉亚洲博彩公司 ：与抑郁症相关威廉亚洲博彩公司 ：

有关抑郁症更多威廉亚洲博彩公司

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 日本专家共识：抑郁症的药物治疗.pdf), AttachmentFileName(sort=100, fileName=2020 日本专家共识：抑郁症的药物治疗)] GetToolGuiderByIdResponse(projectId=1, id=2aa881c00186e2bb, title=2020 日本专家共识：抑郁症的药物治疗, enTitle=Pharmacological management of depression: Japanese expert consensus., guiderFrom=J Affect Disord. 2020 Jan 28;266:626-632., authorId=null, author=, summary=2020年1月，日本临床神经精神药理学学会(JSCNP)发布了抑郁症的药物治疗专家共识，真实世界抑郁症治疗的临床相关问题并没总被常规治疗威廉亚洲博彩公司 所涉及，日本临床神经精神药理学学会(JSCNP)专家组对23种抑郁症临床治疗情况的治疗方案进行评估，形成专家共识。 , cover=, journalId=null, articlesId=null, associationId=1320, associationName=国外精神科相关专家小组（统称）, associationIntro=, copyright=0, guiderPublishedTime=Tue Jan 28 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p>2020年1月，日本临床神经精神药理学学会(JSCNP)发布了抑郁症的药物治疗专家共识，真实世界抑郁症治疗的临床相关问题并没总被常规治疗威廉亚洲博彩公司 所涉及，日本临床神经精神药理学学会(JSCNP)专家组对23种抑郁症临床治疗情况的治疗方案进行评估，形成专家共识。</p> <p>&nbsp;</p> <p>拓展威廉亚洲博彩公司 ：<strong>与<span style="color: red;">抑郁症</span>相关威廉亚洲博彩公司 ：</strong></p> <ul> <ul> <li><a title="2019 ISNPR实践威廉亚洲博彩公司 ：应用Omega-3脂肪酸治疗抑郁症" href="//www.nyrain.com/guideline/show_article.do?id=f34111c001e899f4" target="_blank" rel="noopener">2019 ISNPR实践威廉亚洲博彩公司 ：应用Omega-3脂肪酸治疗抑郁症</a></li> <li><a title="2019 临床实践威廉亚洲博彩公司 ：抑郁症与特定精神疾病共病的管理" href="//www.nyrain.com/guideline/show_article.do?id=fbc051c001698e08" target="_blank" rel="noopener">2019 临床实践威廉亚洲博彩公司 ：抑郁症与特定精神疾病共病的管理</a></li> <li><a title="阿戈美拉汀治疗抑郁症临床应用专家建议" href="//www.nyrain.com/guideline/show_article.do?id=2a53f1c0016e30c8" target="_blank" rel="noopener">阿戈美拉汀治疗抑郁症临床应用专家建议</a></li> <li><a title="2018 AAP威廉亚洲博彩公司 ：基层医疗中青少年抑郁症的管理" href="//www.nyrain.com/guideline/show_article.do?id=19d8b1c0015628c0" target="_blank" rel="noopener">2018 AAP威廉亚洲博彩公司 ：基层医疗中青少年抑郁症的管理</a></li> <li><a title="2017 佛罗里达最佳实践威廉亚洲博彩公司 ：成人抑郁症的药物治疗" href="//www.nyrain.com/guideline/show_article.do?id=6992d1c001a89662" target="_blank" rel="noopener">2017 佛罗里达最佳实践威廉亚洲博彩公司 ：成人抑郁症的药物治疗</a></li> 更多信息请点击：</ul> </ul> <p><a href="//www.nyrain.com/guideline/list.do?q=%E6%8A%91%E9%83%81%E7%97%87" target="_blank" rel="noopener">有关抑郁症更多威廉亚洲博彩公司 </a></p>, tagList=[TagDto(tagId=228, tagName=抑郁症), TagDto(tagId=1113, tagName=药物治疗)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=24859, appHits=618, showAppHits=12, pcHits=4565, showPcHits=23664, likes=11, shares=25, comments=12, approvalStatus=1, publishedTime=Mon Feb 24 22:59:46 CST 2020, publishedTimeString=2020-01-28, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon Feb 24 22:59:46 CST 2020, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 03:39:24 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 日本专家共识：抑郁症的药物治疗.pdf), AttachmentFileName(sort=100, fileName=2020 日本专家共识：抑郁症的药物治疗)])
2020 日本专家共识：抑郁症的药物治疗.pdf
下载请点击：
2020 日本专家共识：抑郁症的药物治疗
下载请点击：
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2099837, encodeId=c4df209983ec0, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Fri Nov 11 10:45:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078290, encodeId=707f10e82903d, content=详细, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d7c1341677, createdName=50277, createdTime=Thu Dec 09 07:00:46 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075660, encodeId=969a10e5660a6, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=041c5414352, createdName=ms2000001862732309, createdTime=Wed Dec 01 04:10:44 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997388, encodeId=f3e399e38878, content=有中文的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eb85544113, createdName=ms5000001821826490, createdTime=Thu Jul 08 06:16:10 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969203, encodeId=b809969203c1, content=謝謝, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a0d2a11691b24091b5b9dbfbadf81dc9/2fdf08a8d767479e869c7752c34716dc.jpg, createdBy=c3915509274, createdName=Ineslou, createdTime=Fri May 28 13:37:58 CST 2021, time=2021-05-28, status=1, ipAttribution=)]
    2022-11-11 ozzy

    非常好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2099837, encodeId=c4df209983ec0, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Fri Nov 11 10:45:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078290, encodeId=707f10e82903d, content=详细, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d7c1341677, createdName=50277, createdTime=Thu Dec 09 07:00:46 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075660, encodeId=969a10e5660a6, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=041c5414352, createdName=ms2000001862732309, createdTime=Wed Dec 01 04:10:44 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997388, encodeId=f3e399e38878, content=有中文的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eb85544113, createdName=ms5000001821826490, createdTime=Thu Jul 08 06:16:10 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969203, encodeId=b809969203c1, content=謝謝, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a0d2a11691b24091b5b9dbfbadf81dc9/2fdf08a8d767479e869c7752c34716dc.jpg, createdBy=c3915509274, createdName=Ineslou, createdTime=Fri May 28 13:37:58 CST 2021, time=2021-05-28, status=1, ipAttribution=)]
    2021-12-09 50277

    详细

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2099837, encodeId=c4df209983ec0, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Fri Nov 11 10:45:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078290, encodeId=707f10e82903d, content=详细, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d7c1341677, createdName=50277, createdTime=Thu Dec 09 07:00:46 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075660, encodeId=969a10e5660a6, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=041c5414352, createdName=ms2000001862732309, createdTime=Wed Dec 01 04:10:44 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997388, encodeId=f3e399e38878, content=有中文的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eb85544113, createdName=ms5000001821826490, createdTime=Thu Jul 08 06:16:10 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969203, encodeId=b809969203c1, content=謝謝, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a0d2a11691b24091b5b9dbfbadf81dc9/2fdf08a8d767479e869c7752c34716dc.jpg, createdBy=c3915509274, createdName=Ineslou, createdTime=Fri May 28 13:37:58 CST 2021, time=2021-05-28, status=1, ipAttribution=)]
    2021-12-01 ms2000001862732309

    赞

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2099837, encodeId=c4df209983ec0, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Fri Nov 11 10:45:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078290, encodeId=707f10e82903d, content=详细, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d7c1341677, createdName=50277, createdTime=Thu Dec 09 07:00:46 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075660, encodeId=969a10e5660a6, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=041c5414352, createdName=ms2000001862732309, createdTime=Wed Dec 01 04:10:44 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997388, encodeId=f3e399e38878, content=有中文的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eb85544113, createdName=ms5000001821826490, createdTime=Thu Jul 08 06:16:10 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969203, encodeId=b809969203c1, content=謝謝, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a0d2a11691b24091b5b9dbfbadf81dc9/2fdf08a8d767479e869c7752c34716dc.jpg, createdBy=c3915509274, createdName=Ineslou, createdTime=Fri May 28 13:37:58 CST 2021, time=2021-05-28, status=1, ipAttribution=)]
    2021-07-08 ms5000001821826490

    有中文的吗

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2099837, encodeId=c4df209983ec0, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Fri Nov 11 10:45:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078290, encodeId=707f10e82903d, content=详细, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d7c1341677, createdName=50277, createdTime=Thu Dec 09 07:00:46 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075660, encodeId=969a10e5660a6, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=041c5414352, createdName=ms2000001862732309, createdTime=Wed Dec 01 04:10:44 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997388, encodeId=f3e399e38878, content=有中文的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7eb85544113, createdName=ms5000001821826490, createdTime=Thu Jul 08 06:16:10 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969203, encodeId=b809969203c1, content=謝謝, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/a0d2a11691b24091b5b9dbfbadf81dc9/2fdf08a8d767479e869c7752c34716dc.jpg, createdBy=c3915509274, createdName=Ineslou, createdTime=Fri May 28 13:37:58 CST 2021, time=2021-05-28, status=1, ipAttribution=)]
    2021-05-28 Ineslou

    謝謝

    0

相关威廉亚洲博彩公司

2019 ISNPR实践威廉亚洲博彩公司 ：应用Omega-3脂肪酸治疗抑郁症

国外精神科相关专家小组（统称） · 2019-09-03

2019 临床实践威廉亚洲博彩公司 ：抑郁症与特定精神疾病共病的管理

国外精神科相关专家小组（统称） · 2019-01-30

阿戈美拉汀治疗抑郁症临床应用专家建议

中国精神科相关专家小组 · 2018-11-30

2018 AAP威廉亚洲博彩公司 ：基层医疗中青少年抑郁症的管理

美国儿科学会(AAP,American Academy of Pediatrics) · 2018-02-26

2017 佛罗里达最佳实践威廉亚洲博彩公司 ：成人抑郁症的药物治疗

国外精神科相关专家小组（统称） · 2017-06-10

2015 BAP循证威廉亚洲博彩公司 ：抗抑郁药治疗抑郁症（修订2008版）

英国精神药理协会(BAP,British Association for Psychopharmacology) · 2015-05-12